Roobol MJ
Roobol MJ
Professor Decision making in Urology
Verified email at
Cited by
Cited by
Screening and prostate-cancer mortality in a randomized European study
FH Schröder, J Hugosson, MJ Roobol, TLJ Tammela, S Ciatto, V Nelen, ...
New England journal of medicine 360 (13), 1320-1328, 2009
MRI-targeted or standard biopsy for prostate-cancer diagnosis
V Kasivisvanathan, AS Rannikko, M Borghi, V Panebianco, LA Mynderse, ...
New England Journal of Medicine 378 (19), 1767-1777, 2018
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
FH Schröder, J Hugosson, MJ Roobol, TLJ Tammela, M Zappa, V Nelen, ...
The Lancet 384 (9959), 2027-2035, 2014
Prostate-cancer mortality at 11 years of follow-up
FH Schröder, J Hugosson, MJ Roobol, TLJ Tammela, S Ciatto, V Nelen, ...
New England Journal of Medicine 366 (11), 981-990, 2012
Prostate-cancer mortality at 11 years of follow-up
FH Schroder, J Hugosson, MJ Roobol, TLJ Tammela, S Ciatto, V Nelen, ...
New England Journal of Medicine 366 (11), 981-990, 2012
Magnetic resonance imaging–targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided …
IG Schoots, MJ Roobol, D Nieboer, CH Bangma, EW Steyerberg, ...
European urology 68 (3), 438-450, 2015
Active surveillance for low-risk prostate cancer worldwide: the PRIAS study
M Bul, X Zhu, R Valdagni, T Pickles, Y Kakehi, A Rannikko, A Bjartell, ...
European urology 63 (4), 597-603, 2013
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
FR Schumacher, AA Al Olama, SI Berndt, S Benlloch, M Ahmed, ...
Nature genetics 50 (7), 928-936, 2018
Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program
R Raaijmakers, WJ Kirkels, MJ Roobol, MF Wildhagen, FH Schrder
Urology 60 (5), 826-830, 2002
Quality-of-life effects of prostate-specific antigen screening
EAM Heijnsdijk, EM Wever, A Auvinen, J Hugosson, S Ciatto, V Nelen, ...
New England Journal of Medicine 367 (7), 595-605, 2012
A risk-based strategy improves prostate-specific antigen–driven detection of prostate cancer
MJ Roobol, EW Steyerberg, R Kranse, T Wolters, RCN van den Bergh, ...
European urology 57 (1), 79-85, 2010
Infectious complications and hospital admissions after prostate biopsy in a European randomized trial
S Loeb, S van den Heuvel, X Zhu, CH Bangma, FH Schröder, MJ Roobol
European urology 61 (6), 1110-1114, 2012
Prostate MRI, with or without MRI‐targeted biopsy, and systematic biopsy for detecting prostate cancer
FJH Drost, DF Osses, D Nieboer, EW Steyerberg, CH Bangma, ...
Cochrane Database of Systematic Reviews, 2019
Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram
EW Steyerberg, MJ Roobol, MW Kattan, TH Van der Kwast, HJ De Koning, ...
The Journal of urology 177 (1), 107-112, 2007
Reporting and interpreting decision curve analysis: a guide for investigators
B Van Calster, L Wynants, JFM Verbeek, JY Verbakel, E Christodoulou, ...
European urology 74 (6), 796-804, 2018
Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly
RCN van den Bergh, S Roemeling, MJ Roobol, G Aus, J Hugosson, ...
European urology 55 (1), 1-8, 2009
Large‐scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal …
HJ de Koning, A Auvinen, A Berenguer Sanchez, F Calais da Silva, ...
International Journal of Cancer 97 (2), 237-244, 2002
Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection
FH Jansen, RHN van Schaik, J Kurstjens, W Horninger, H Klocker, ...
European urology 57 (6), 921-927, 2010
A decade of active surveillance in the PRIAS study: an update and evaluation of the criteria used to recommend a switch to active treatment
LP Bokhorst, R Valdagni, A Rannikko, Y Kakehi, T Pickles, CH Bangma, ...
European urology 70 (6), 954-960, 2016
A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
J Hugosson, MJ Roobol, M Månsson, TLJ Tammela, M Zappa, V Nelen, ...
European urology 76 (1), 43-51, 2019
The system can't perform the operation now. Try again later.
Articles 1–20